Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Henry Ford Health System |
---|---|
Information provided by: | Henry Ford Health System |
ClinicalTrials.gov Identifier: | NCT00757315 |
Acne Keloidalis Nuchae (AKN) is a long standing hair follicle disease with bumps and scars on the skin of the back of the head and neck. The purpose of this new study is to determine how well a hair removal laser (NdYag Laser) works in treating AKN.
Condition | Intervention |
---|---|
Acne Keloidalis Nuchae NdYag Laser AKN Acne Keloidalis AK Dermatitis Papillaris Capillitii Folliculitis Keloidalis Nuchae Sycosis Nuchae Acne Keloid Keloidal Folliculitis Lichen Keloidalis Nuchae Folliculitis Nuchae Scleroticans Sycosis Framboesiformis |
Device: NdYag Laser(hair removal laser) plus topical corticosteroid Drug: Topical corticosteroid alone |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Prospective, Controlled Study of the Efficacy of NdYag for Acne Keloidalis Nuchae |
Estimated Enrollment: | 30 |
Study Start Date: | September 2008 |
Estimated Study Completion Date: | December 2009 |
Estimated Primary Completion Date: | September 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental |
Device: NdYag Laser(hair removal laser) plus topical corticosteroid
NdYag laser and topical corticosteroid are applied to one half of the scalp.
|
2: Active Comparator |
Drug: Topical corticosteroid alone
topical corticosteroid alone is applied to one half of the scalp
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
For inclusion, the subject must:
Exclusion Criteria:
Subject must not:
Contact: Marsha D Henderson, MD | 313-916-6964 | mhender4@hfhs.org |
United States, Michigan | |
Henry Ford Medical Center, New Center One | Recruiting |
Detroit, Michigan, United States, 48202 | |
Contact: Marsha D Henderson, MD 313-916-6964 mhender4@hfhs.org | |
Principal Investigator: Iltefat H Hamzavi, MD | |
Sub-Investigator: Richard H Huggins, MD | |
Sub-Investigator: Bassel H Mahmoud, MD, PhD | |
Sub-Investigator: Dakara Wright, MD | |
Sub-Investigator: Denise Woo, MD | |
Sub-Investigator: Marsha D Henderson, MD |
Principal Investigator: | Iltefat H Hamzavi, MD | Henry Ford Health Systems Dermatology Department |
Responsible Party: | Henry Ford Hospital Department of Dermatology ( Iltefat H. Hamzavi MD ) |
Study ID Numbers: | 5244 |
Study First Received: | September 22, 2008 |
Last Updated: | August 27, 2009 |
ClinicalTrials.gov Identifier: | NCT00757315 History of Changes |
Health Authority: | United States: Institutional Review Board |
acne keloidalis nuchae NdYag laser AKN acne keloidalis AK dermatitis papillaris capillitii folliculitis keloidalis nuchae |
sycosis nuchae acne keloid keloidal folliculitis lichen keloidalis nuchae folliculitis nuchae scleroticans sycosis framboesiformis |
Anti-Inflammatory Agents Facial Dermatoses Skin Diseases Facies Collagen Diseases Keloid Hormone Antagonists Acne Keloid Hormones, Hormone Substitutes, and Hormone Antagonists Triamcinolone diacetate Sebaceous Gland Diseases |
Hormones Glucocorticoids Acne Vulgaris Triamcinolone hexacetonide Exanthema Triamcinolone Acetonide Triamcinolone Connective Tissue Diseases Folliculitis Dermatitis Cicatrix |
Anti-Inflammatory Agents Hair Diseases Facial Dermatoses Skin Diseases Collagen Diseases Keloid Acne Keloid Physiological Effects of Drugs Hormones, Hormone Substitutes, and Hormone Antagonists Sebaceous Gland Diseases Hormones |
Glucocorticoids Pharmacologic Actions Acne Vulgaris Acneiform Eruptions Therapeutic Uses Triamcinolone Connective Tissue Diseases Folliculitis Dermatitis Cicatrix |